Literature DB >> 24719593

Oral Absorption of Enteral Vancomycin in a Child with Clostridium difficile Colitis and Renal Impairment.

Adam Wood1, Katie Wassil2, Elisa Edwards2.   

Abstract

Vancomycin is a glycopeptide antibiotic that is used by the enteral route for the treatment of Clostridium difficile infections and is not thought to be absorbed into the systemic circulation. We report on a 2-year-old, 12.5-kg patient with confirmed C difficile colitis and renal insufficiency that was treated with 125 mg of enteral vancomycin (10 mg/kg); the patient developed measurable systemic concentrations as high as 17.8 mg/L. However, as the patient's colitis began to improve, the serial vancomycin concentrations reflected little to no continued absorption of vancomycin. A review of the literature regarding this rare phenomenon is discussed.

Entities:  

Keywords:  Clostridium difficile; pharmacokinetics; vancomycin

Year:  2013        PMID: 24719593      PMCID: PMC3979055          DOI: 10.5863/1551-6776-18.4.315

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  8 in total

1.  Systemic absorption of vancomycin.

Authors:  C J Armstrong; T S Wilson
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

2.  Systemic absorption of enteral vancomycin in a patient with pseudomembranous colitis.

Authors:  P G Spitzer; G M Eliopoulos
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

3.  Systemic absorption of oral vancomycin in patients with Clostridium difficile infection.

Authors:  Sriharsha Rao; Yizhak Kupfer; Murali Pagala; Edward Chapnick; Sidney Tessler
Journal:  Scand J Infect Dis       Date:  2011-01-03

4.  Significant absorption of oral vancomycin in a patient with clostridium difficile colitis and normal renal function.

Authors:  Sangita Aradhyula; Farrin A Manian; Saad A S Hafidh; Saqib S Bhutto; Martin A Alpert
Journal:  South Med J       Date:  2006-05       Impact factor: 0.954

5.  Absorption of oral vancomycin - possible associated toxicity.

Authors:  C M Thompson; S S Long; P H Gilligan; J W Prebis
Journal:  Int J Pediatr Nephrol       Date:  1983-03

6.  Unexpected serum level of vancomycin after oral administration in a patient with severe colitis and renal insufficiency.

Authors:  S Yamazaki; H Nakamura; S Yamagata; G Miura; N Hattori; K Shinozaki; T Sadahiro; A Toyoda; H Nakasa; N Ariyoshi; S Oda; K Harigaya; M Kitada
Journal:  Int J Clin Pharmacol Ther       Date:  2009-11       Impact factor: 1.366

Review 7.  Possible red-man syndrome associated with systemic absorption of oral vancomycin in a child with normal renal function.

Authors:  L Bergeron; F D Boucher
Journal:  Ann Pharmacother       Date:  1994-05       Impact factor: 3.154

8.  Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitis.

Authors:  G R Matzke; C E Halstenson; P L Olson; A J Collins; P A Abraham
Journal:  Am J Kidney Dis       Date:  1987-05       Impact factor: 8.860

  8 in total
  1 in total

Review 1.  Does oral vancomycin use necessitate therapeutic drug monitoring?

Authors:  Nevio Cimolai
Journal:  Infection       Date:  2019-11-11       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.